Additional features that were associated with poor prognosis in the large case series studied by panel and exome sequencing included grade 3 ILC, an ER-negative phenotype, mutations in TP53 or ERBB2, and a high tumour substitution mutation burden (>5 mutations/Mb). Here, ERBB2 is linked to neoplasm.